Texas Yale Capital Corp’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,851
Closed -$232K 435
2019
Q4
$232K Hold
10,851
0.02% 425
2019
Q3
$249K Hold
10,851
0.02% 407
2019
Q2
$214K Sell
10,851
-10,851
-50% -$211K 0.02% 432
2019
Q1
$422K Buy
21,702
+10,841
+100% +$205K 0.02% 419
2018
Q4
$179K Sell
10,861
-50
-0.5% -$1.01K 0.02% 402
2018
Q3
$252K Hold
10,911
0.02% 407
2018
Q2
$237K Sell
10,911
-279
-2% -$5.45K 0.02% 410
2018
Q1
$198K Sell
11,190
-3,210
-22% -$56.6K 0.02% 433
2017
Q4
$270K Buy
14,400
+579
+4% +$11.5K 0.02% 408
2017
Q3
$303K Buy
+13,821
New +$312K 0.03% 390

Other funds holding SBRA

Texas Yale Capital Corp's SBRA Position: Q1 2020 in Review

Texas Yale Capital Corp sold out of Sabra Healthcare REIT (SBRA) in Q1 2020, closing a stake of 10,851 shares — an estimated $232K sold.

Texas Yale Capital Corp first reported a position in SBRA in Q3 2017 and held it in 10 quarters. The position peaked at $422K in Q1 2019. 324 funds tracked by Wall St. Rank hold SBRA as of Q1 2020.

  • Texas Yale Capital Corp reported no remaining Sabra Healthcare REIT position as of Q1 2020 after selling out during the quarter.
  • Texas Yale Capital Corp sold 10,851 Sabra Healthcare REIT shares in Q1 2020, an estimated $232K.
  • Texas Yale Capital Corp first reported a position in Sabra Healthcare REIT in Q3 2017 and held it in 10 quarters.
  • Texas Yale Capital Corp's Sabra Healthcare REIT position peaked at $422K in Q1 2019.
  • 324 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2020.

Based on Texas Yale Capital Corp's 13F filing for Q1 2020, filed 13 May 2020.